People with hospital-treated infections in early- and mid-life had the greatest risk of Alzheimer’s and Parkinson’s diseases later in life.
Infections treated with specialty hospital care in early- and mid-life are associated with an increased subsequent risk of Alzheimer’s (AD) and Parkinson’s diseases (PD), but not amyotrophic lateral sclerosis (ALS). This is according to a new study published recently in the open-access journal PLOS Medicine by Jiangwei Sun of Karolinska Institute, Sweden, and colleagues.
According to the CDC, an estimated 6.5 million Americans are living with Alzheimer’s disease. Nearly one million people in the U.S. are living with Parkinson’s disease, according to the Parkinson’s Foundation.
Experimental studies in animals have indicated that infection plays a role in the development of some neurodegenerative diseases. However, supporting evidence in humans is limited. In the new study, scientists used data on people diagnosed with AD, PD, or ALS from 1970-2016 in Sweden, as well as five matched controls per case, all identified from the Swedish National Patient Register. The analysis included 291,941 AD cases, 103,919 PD cases, and 10,161 ALS cases.
Stronger Associations for Early-Life Infections
A hospital-treated infection 5 or more years before diagnosis was associated with a 16% higher risk of AD (95%CI: 1.15-1.18, P < 0.001) and a 4% higher risk of PD (95%CI: 1.02-1.06, P < 0.001), with similar risks seen for bacterial, viral and other infections and for different sites of infection. The highest risk of disease was seen in people with multiple hospital-treated infections before the age of 40, with more than double the risk of AD (OR=2.62, 95%CI: 2.52-2.72, P < 0.001) and more than 40% increase in the risk of PD (OR=1.41, 95%CI: 1.29-1.53, 3 44 P < 0.001). No association was observed for ALS, regardless of age at diagnosis.
“These findings suggest that infectious events may be a trigger or amplifier of a pre-existing disease process, leading to clinical onset of neurodegenerative disease at a relatively early age,” the authors say, while also pointing out that “due to the observational nature of the study, these results do not formally prove a causal link.”
Sun adds, “Hospital-treated infections, especially in early- and mid-life, were associated with an increased risk of Alzheimer’s disease (AD) and Parkinson’s disease (PD), primarily among AD and PD cases diagnosed before 60 years.”
Reference: “Hospital-treated infections in early- and mid-life and risk of Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis: A nationwide nested case-control study in Sweden” by Jiangwei Sun, Jonas F. Ludvigsson, Caroline Ingre, Fredrik Piehl, Karin Wirdefeldt, Ulrika Zagai, Weimin Ye and Fang Fang, 15 September 2022, PLoS Medicine.
DOI: 10.1371/journal.pmed.1004092
Funding: This study was supported by the Swedish Research Council (grants No: 2019-01088 (FF), 340-2013-5867 (FF), and 2017-02175 (KW)), the Joint Program on Neurodegenerative Diseases (JPND, grant number: 2021-00696 (FF)), and the Chinese Scholarship Council (JS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Never miss a breakthrough: Join the SciTechDaily newsletter.
Follow us on Google and Google News.
1 Comment
What constitutes a “hospital-treated infection?” Tonsils, appendicitis, measles, mumps, any or all? I guess “hospital-treated” is key…does that include surgery?
Thanks, Joan VT